An Act relative to preventing overdose deaths and increasing access to treatment
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This bill aims to reduce overdose deaths and expand access to treatment for substance use disorders in Massachusetts. It seeks to improve the availability of naloxone, a medication that can reverse opioid overdoses, and increase access to medication-assisted treatment programs. The legislation also intends to support harm reduction services and expand the capacity of treatment facilities. The bill is currently under consideration by the Senate Ways and Means Committee.
Key provisions
- Increase access to naloxone for individuals and communities.
- Expand medication-assisted treatment programs for substance use disorders.
- Support harm reduction services, such as syringe exchange programs.
- Increase funding for overdose prevention and response efforts.
- Promote training on recognizing and responding to overdoses.
- Expand access to behavioral health services.
- Support the development of treatment facilities.
Who is affected
- Individuals struggling with substance use disorders
- Families affected by substance use disorders
- Healthcare providers
- Public health officials
- Community organizations
Notable changes
- The bill focuses on expanding access to both medication-assisted treatment and harm reduction strategies.
- It aims to address the opioid crisis through a multi-faceted approach.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
16 on record
Primary sponsor
Cosponsors
James B. Eldridge
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours